Which hormones promote breast cancer in postmenopause: Estrogens, progestins, insulin and/or adipocytokines?

被引:0
|
作者
Jamin, C. [1 ]
机构
[1] AFACS, F-75008 Paris, France
来源
GYNECOLOGIE OBSTETRIQUE & FERTILITE | 2010年 / 38卷 / 01期
关键词
DIETARY GLYCEMIC INDEX; PHYSICAL-ACTIVITY; PLUS PROGESTIN; FATTY-ACIDS; RISK; WOMEN; RESISTANCE; MORTALITY; SURVIVAL; THERAPY;
D O I
10.1016/j.gyobfe.2009.11.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [31] Insulin glargine and (A21Gly,DiD-Arg) insulin do not promote breast cancer growth in a mouse model
    Gallagher, E.
    Tennagels, N.
    Werner, U.
    LeRoith, D.
    DIABETOLOGIA, 2015, 58 : S262 - S262
  • [32] The Cholesterol Metabolite 27HC Increases Secretion of Extracellular Vesicles Which Promote Breast Cancer Progression
    Baek, Amy E.
    Krawczynska, Natalia
    Das Gupta, Anasuya
    Dvoretskiy, Svyatoslav Victorovich
    You, Sixian
    Park, Jaena
    Deng, Yu-Heng
    Sorrells, Janet E.
    Smith, Brandi Patrice
    Ma, Liqian
    Nelson, Adam T.
    McDowell, Hannah B.
    Sprenger, Ashabari
    Henn, Madeline A.
    Madak-Erdogan, Zeynep
    Kong, Hyunjoon
    Boppart, Stephen A.
    Boppart, Marni D.
    Nelson, Erik R.
    ENDOCRINOLOGY, 2021, 162 (07)
  • [33] Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors
    Sharon J. Wayne
    Marian L. Neuhouser
    Cornelia M. Ulrich
    Carol Koprowski
    Kathy B. Baumgartner
    Richard N. Baumgartner
    Anne McTiernan
    Leslie Bernstein
    Rachel Ballard-Barbash
    Breast Cancer Research and Treatment, 2008, 112 : 149 - 158
  • [34] Dietary fiber is associated with serum sex hormones and insulin-related peptides in postmenopausal breast cancer survivors
    Wayne, Sharon J.
    Neuhouser, Marian L.
    Ulrich, Cornelia M.
    Koprowski, Carol
    Baumgartner, Kathy B.
    Baumgartner, Richard N.
    McTiernan, Anne
    Bernstein, Leslie
    Ballard-Barbash, Rachel
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (01) : 149 - 158
  • [35] Adipocytokines and Insulin Resistance: Their Role as Benign Breast Disease and Breast Cancer Risk Factors in a High-Prevalence Overweight-Obesity Group of Women over 40 Years Old
    Sat-Munoz, Daniel
    Martinez-Herrera, Brenda-Eugenia
    Quiroga-Morales, Luis-Aaron
    Trujillo-Hernandez, Benjamin
    Gonzalez-Rodriguez, Javier-Andres
    Gutierrez-Rodriguez, Leonardo-Xicotencatl
    Leal-Cortes, Caridad-Aurea
    Portilla-de-Buen, Eliseo
    Rubio-Jurado, Benjamin
    Salazar-Paramo, Mario
    Gomez-Sanchez, Eduardo
    Delgadillo-Cristerna, Raul
    Carrillo-Nunez, Gabriela-Guadalupe
    Nava-Zavala, Arnulfo-Hernan
    Balderas-Pena, Luz-Ma-Adriana
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (10)
  • [36] MODULATION OF THE GROWTH-INHIBITORY EFFECTS OF PROGESTINS AND THE ANTIESTROGEN HYDROXYCLOMIPHENE ON HUMAN-BREAST CANCER-CELLS BY EPIDERMAL GROWTH-FACTOR AND INSULIN
    KOGA, M
    MUSGROVE, EA
    SUTHERLAND, RL
    CANCER RESEARCH, 1989, 49 (01) : 112 - 116
  • [37] Insulin Glargine and Human Insulin Promote Proliferation of a Human Breast Cancer Cell Line MDA-MB-231 Independent of ERK Pathway
    Liu, Shanying
    Yan Li
    Ying Liang
    Fan, Xinlan
    Liang, Qijun
    Li Yan
    DIABETES, 2010, 59 : A651 - A651
  • [38] EFFECTS OF SERUM AND INSULIN ON THE SENSITIVITY OF THE HUMAN-BREAST CANCER CELL LINE-MCF-7 TO ESTROGEN AND ANTI-ESTROGENS
    BUTLER, WB
    KELSEY, WH
    GORAN, N
    CANCER RESEARCH, 1981, 41 (01) : 82 - 88
  • [39] ROLE OF INSULIN IN MODIFYING THE RESPONSE OF THE HUMAN-BREAST CANCER CELL-LINE MCF-7 TO ANTI-ESTROGENS
    BUTLER, WB
    KELSEY, WH
    GORAN, N
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 247 - 247
  • [40] Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes
    Gallagher, Emily J.
    Zelenko, Zara
    Tobin-Hess, Aviva
    Werner, Ulrich
    Tennagels, Norbert
    LeRoith, Derek
    DIABETOLOGIA, 2016, 59 (09) : 2018 - 2025